山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2015年
18期
10-13
,共4页
师天明%杨洋%周佩军%徐达%王祥慧%邵琨
師天明%楊洋%週珮軍%徐達%王祥慧%邵琨
사천명%양양%주패군%서체%왕상혜%소곤
肾移植%霉酚酸%药代动力学%中国人
腎移植%黴酚痠%藥代動力學%中國人
신이식%매분산%약대동역학%중국인
kidney transplantation%mycophenolic acid%pharmacokinetics%Chinese
目的:观察服用霉酚酸钠肠溶片( EC-MPS)的国人肾移植受者血中霉酚酸( MPA)的药代动力学特征,建立简化的MPA血浆浓度—时间曲线下面积(AUC)的计算公式。方法30例肾移植受者均接受EC-MPS1.44 g/d联合环孢素、强的松的三联免疫抑制方案。采用EMIT法测服药前及服药后0.5、1、1.5、2、4、6、8、10、12 h的血浆MPA浓度(分别为C0.5、C1、C1.5、C2、C4、C6、C8、C10、C12)。采用药理学专用软件计算MPA AUC0~12 h ,并以多元逐步回归分析法得出适合国人的MPAAUC0~12h的简化计算公式。结果30例肾移植受者EC-MPS的药代动力学参数存在显著个体差异。 MPA AUC0~12 h平均值为(47.64±25.14)mg· h/L。选取2个取样时点的C1.5、C2和4个取样时点的C2、C4、C6、C8,分别得出MPA AUC的简化计算公式:AUC=27.41+0.87×C1.5+0.88×C2(r2=0.67)和AUC=3.98+2.03×C2+2.18×C4+1.91×C6+5.08×C8(r2=0.86),其对MPA AUC预测值的绝对误差分别为(28.8±24.8)%和(12.8±10.1)%;30例肾移植受者中,MPA AUC预测值误差均在MPA AUC0~12 h的±15%以内。结论服用EC-MPS的国人肾移植受者血浆中MPA药代动力学呈现较大的个体差异;得出取样点少(2个取样时点或4个取样时点)、预测效果好的MPA AUC简化计算公式。
目的:觀察服用黴酚痠鈉腸溶片( EC-MPS)的國人腎移植受者血中黴酚痠( MPA)的藥代動力學特徵,建立簡化的MPA血漿濃度—時間麯線下麵積(AUC)的計算公式。方法30例腎移植受者均接受EC-MPS1.44 g/d聯閤環孢素、彊的鬆的三聯免疫抑製方案。採用EMIT法測服藥前及服藥後0.5、1、1.5、2、4、6、8、10、12 h的血漿MPA濃度(分彆為C0.5、C1、C1.5、C2、C4、C6、C8、C10、C12)。採用藥理學專用軟件計算MPA AUC0~12 h ,併以多元逐步迴歸分析法得齣適閤國人的MPAAUC0~12h的簡化計算公式。結果30例腎移植受者EC-MPS的藥代動力學參數存在顯著箇體差異。 MPA AUC0~12 h平均值為(47.64±25.14)mg· h/L。選取2箇取樣時點的C1.5、C2和4箇取樣時點的C2、C4、C6、C8,分彆得齣MPA AUC的簡化計算公式:AUC=27.41+0.87×C1.5+0.88×C2(r2=0.67)和AUC=3.98+2.03×C2+2.18×C4+1.91×C6+5.08×C8(r2=0.86),其對MPA AUC預測值的絕對誤差分彆為(28.8±24.8)%和(12.8±10.1)%;30例腎移植受者中,MPA AUC預測值誤差均在MPA AUC0~12 h的±15%以內。結論服用EC-MPS的國人腎移植受者血漿中MPA藥代動力學呈現較大的箇體差異;得齣取樣點少(2箇取樣時點或4箇取樣時點)、預測效果好的MPA AUC簡化計算公式。
목적:관찰복용매분산납장용편( EC-MPS)적국인신이식수자혈중매분산( MPA)적약대동역학특정,건립간화적MPA혈장농도—시간곡선하면적(AUC)적계산공식。방법30례신이식수자균접수EC-MPS1.44 g/d연합배포소、강적송적삼련면역억제방안。채용EMIT법측복약전급복약후0.5、1、1.5、2、4、6、8、10、12 h적혈장MPA농도(분별위C0.5、C1、C1.5、C2、C4、C6、C8、C10、C12)。채용약이학전용연건계산MPA AUC0~12 h ,병이다원축보회귀분석법득출괄합국인적MPAAUC0~12h적간화계산공식。결과30례신이식수자EC-MPS적약대동역학삼수존재현저개체차이。 MPA AUC0~12 h평균치위(47.64±25.14)mg· h/L。선취2개취양시점적C1.5、C2화4개취양시점적C2、C4、C6、C8,분별득출MPA AUC적간화계산공식:AUC=27.41+0.87×C1.5+0.88×C2(r2=0.67)화AUC=3.98+2.03×C2+2.18×C4+1.91×C6+5.08×C8(r2=0.86),기대MPA AUC예측치적절대오차분별위(28.8±24.8)%화(12.8±10.1)%;30례신이식수자중,MPA AUC예측치오차균재MPA AUC0~12 h적±15%이내。결론복용EC-MPS적국인신이식수자혈장중MPA약대동역학정현교대적개체차이;득출취양점소(2개취양시점혹4개취양시점)、예측효과호적MPA AUC간화계산공식。
Objective To observe the pharmacokinetics features of mycophenolic acid ( MPA) in Chinese renal al-lograft recipients who took Myfortic ( EC-MPS) and to establish a calculation for the abbreviated MPA area under the curve (AUC) of plasma concentration and time .Methods Thirty renal-transplant recipients were treated with EC-MPS (1.44 g/d) in combination with cyclosporine ( CsA) and prednisone ( Pred) .Plasma MPA concentrations were determined by E-MIT method at pre-medication, 0.5, 1, 1.5, 2, 4, 6, 8, 10 and 12 hours (C0.5,C1,C1.5,C2,C4,C6,C8,C10 and C12) af-ter oral administration .The MPA AUC0-12 h were calculated by using the trapezoidal rule and the abbreviated MPA AUC model equation fitted to 30 MPA AUC0-12 h profiles was generated by the multiple regression analysis .Results The phar-macokinetics of EC-MPS in 30 renal-transplant recipients manifested great inter-patient difference . The mean MPA AUC0-12 h was (47.64 ±25.14) mg· h/L.We selected C1.5, and C2 at two different time points and C2, C4, C6 and C8 at four different time points.Then, the abbreviated MPA AUC model equations were recommended:AUC=27.41+0.87 ×C1.5 +0.88 ×C2(r2 =0.67), or AUC=3.98+2.03 ×C2 +2.18 ×C4 +1.91 ×C6 +5.08 ×C8(r2 =0.86);the abso-lute prediction error was (28.8 ±24.8)%and (12.8 ±10.1)%, respectively.In 30 recipients, the absolute prediction error between estimated MPA AUC and full MPAAUC 0-12 h was within ±15%.Conclusions EC-MPS pharmacokinetics in Chinese renal allograft recipients manifests a substantial inter-individual variability .We get the MPA AUC simplified calcu-lation formula, which needs less sampling point and has good predictive effect .